4 ms·
~10K for an effective single-dose treatment is not that expensive. Admittedly this is a very crude calculation, but it's probably not too far off. Moreover, m
by hcknwscommenter 7y ago
~10K for an effective single-dose treatment is not that expensive. Admittedly this is a very crude calculation, but it's probably not too far off. Moreover, mAb production is a very mature technology, that can be scaled up by just growing more cells. I'm not saying we are close to getting this into the clinic, but it is a very interesting result.
- m0zg 7y agoAcross 100M people that's a cool trillion dollars.
- newsbinator 7y agoTrue, but even if we're only talking dollars, we'd have to compare that trillion to the economic amount lost by not inoculating.
- deleted 7y ago[deleted]
- imtringued 7y agoThere would be a lot of dead people but the economic impact of those deaths would be pretty insignificant because highest fatality rate is for people in their 80s.
- op00to 7y agoI think you underestimate the psycho-social effects of having millions of deaths.
- saystupidthings 7y agoAnd if given to the at risk elderly it's like 20% of that. So it seems like a good deal.